Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
Dong Ha Kim, HyeongRyul Kim, Yun Jung Choi, et al.
Experimental & Molecular Medicine (2019) Vol. 51, Iss. 8, pp. 1-13
Open Access | Times Cited: 317

Showing 26-50 of 317 citing articles:

Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions
Juan Liu, Shaoxian Wu, Xiao Zheng, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 77
Exosomal PD-L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies
Kaijian Zhou, Shu Guo, Fei Li, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 77
Extracellular vesicle– and particle-mediated communication shapes innate and adaptive immune responses
Fanny A. Pelissier Vatter, Michele Cioffi, Samer Hanna, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 8
Open Access | Times Cited: 70
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer
Diego Pérez, Alessandro Russo, Óscar Arrieta, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 68
Extracellular and nuclear PD-L1 in modulating cancer immunotherapy
Wenjun Xiong, Yang Gao, Wenyi Wei, et al.
Trends in cancer (2021) Vol. 7, Iss. 9, pp. 837-846
Closed Access | Times Cited: 65
The role of exosomes in lung cancer metastasis and clinical applications: an updated review
Lei Yin, Xiaotian Liu, Xuejun Shao, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 65
Exosomal Proteins and Lipids as Potential Biomarkers for Lung Cancer Diagnosis, Prognosis, and Treatment
Ming-Tsung Hsu, Yu-Ke Wang, Yufeng Jane Tseng
Cancers (2022) Vol. 14, Iss. 3, pp. 732-732
Open Access | Times Cited: 65
Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells
Mingyao Huang, Xin Huang, Ning Huang
Cancer Science (2022) Vol. 113, Iss. 6, pp. 1968-1983
Open Access | Times Cited: 65
HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8+ T-cell infiltration into tumors
Lei Guan, Bin Wu, Ting Li, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 56
Radiation-induced PD-L1 expression in tumor and its microenvironment facilitates cancer-immune escape: a narrative review
Nuo-Han Wang, Zheng Lei, Hao-Nan Yang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1406-1406
Open Access | Times Cited: 46
Extracellular vesicles in cancer therapy
Shizhen Emily Wang
Seminars in Cancer Biology (2022) Vol. 86, pp. 296-309
Open Access | Times Cited: 44
Extracellular vesicles as next generation immunotherapeutics
David W. Greening, Rong Xu, Anukreity Ale, et al.
Seminars in Cancer Biology (2023) Vol. 90, pp. 73-100
Closed Access | Times Cited: 41
Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity
Wenqun Zhong, Youtao Lu, Xuexiang Han, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113224-113224
Open Access | Times Cited: 33
Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology
Karama Asleh, Valerie Dery, Cathy Taylor, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 32
Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors
Wenqun Zhong, Zebin Xiao, Zhiyuan Qin, et al.
Cancer Research (2023) Vol. 83, Iss. 16, pp. 2790-2806
Open Access | Times Cited: 30
Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer
Dong Ha Kim, Hyojeong Park, Yun Jung Choi, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Extracellular vesicles and particles as mediators of long-range communication in cancer: connecting biological function to clinical applications
Tetsuhiko Asao, Gabriel Cardial Tobias, Serena Lucotti, et al.
Extracellular Vesicles and Circulating Nucleic Acids (2023) Vol. 4, Iss. 3, pp. 461-485
Open Access | Times Cited: 26
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
Kabsoo Shin, Joori Kim, Se Jun Park, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Tumor-derived nanoseeds condition the soil for metastatic organotropism
Mengying Hu, Candia M. Kenific, Nancy Boudreau, et al.
Seminars in Cancer Biology (2023) Vol. 93, pp. 70-82
Closed Access | Times Cited: 23
Liquid biopsy in lung cancer
Lan Li, Haixia Jiang, Bingjie Zeng, et al.
Clinica Chimica Acta (2024) Vol. 554, pp. 117757-117757
Closed Access | Times Cited: 14
NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy
Leona Rašková Kafková, Joanna Maria Mierzwicka, Prosenjit Chakraborty, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 14
Tumor‐derived exosomal PD-L1: a new perspective in PD-1/PD-L1 therapy for lung cancer
Yunjiao Wu, Huichao Fu, Jingwei Hao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Precise analysis of single small extracellular vesicles using flow cytometry
Hisano Kobayashi, Shiba Takayuki, Takeshi Yoshida, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
Siyuan Wang, Jiaxin Wang, Yu Xia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Label-Free Multiplex Profiling of Exosomal Proteins with a Deep Learning-Driven 3D Surround-Enhancing SERS Platform for Early Cancer Diagnosis
Miao Chen, Haoyang Wang, Yibin Zhang, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 17, pp. 6794-6801
Closed Access | Times Cited: 11

Scroll to top